Artificial intelligence (AI) is increasingly applied to clinical trial risk assessment, aiming to improve safety and efficiency. This scoping review analyzed 142 studies published between 2013 and 2024, focusing on safety (nā=ā55), efficacy (nā=ā46),...
read more